Literature DB >> 9038657

1976 and all that!--20 years of antisecretory therapy.

A Garner1, H Fadlallah, M E Parsons.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 9038657      PMCID： PMC1383447          DOI： 10.1136/gut.39.6.784

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  26 in total

1.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

2.  Attempt to fulfil Koch's postulates for pyloric Campylobacter.

Authors:  B J Marshall; J A Armstrong; D B McGechie; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

Review 3.  Histamine H2-antagonists--past, present and future.

Authors:  R T Brittain; D Jack
Journal:  J Clin Gastroenterol       Date:  1983       Impact factor: 3.062

4.  Reminiscences of the development of cimetidine.

Authors:  W A Duncan; M E Parsons
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

5.  Pharmacological basis for the induction of gastric carcinoid tumours in the rat by loxtidine, an insurmountable histamine H2-receptor blocking drug.

Authors:  R T Brittain; D Jack; J J Reeves; R Stables
Journal:  Br J Pharmacol       Date:  1985-08       Impact factor: 8.739

6.  Effect of a new potent H2-blocker, 3-[[[2-(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N2-sulfamoyl propionamidine (YM-11170), on gastric secretion, ulcer formation and weight of male accessory sex organs in rats.

Authors:  M Takeda; T Takagi; Y Yashima; H Maeno
Journal:  Arzneimittelforschung       Date:  1982

7.  A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.

Authors:  R L Cavanagh; J J Usakewicz; J P Buyniski
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

8.  Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine.

Authors:  M J Daly; J M Humphray; R Stables
Journal:  Br J Pharmacol       Date:  1981-01       Impact factor: 8.739

9.  Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate.

Authors:  D F Martin; D Hollanders; S J May; M M Ravenscroft; D E Tweedle; J P Miller
Journal:  Lancet       Date:  1981-01-03       Impact factor: 79.321

10.  Vaccination and mucosal responses to Helicobacter pylori infection.

Authors:  A Lee; F Buck
Journal:  Aliment Pharmacol Ther       Date:  1996-04       Impact factor: 8.171
View more
  7 in total

1.  Effect of repeated doses of netazepide, a gastrin receptor antagonist, omeprazole and placebo on 24 h gastric acidity and gastrin in healthy subjects.

Authors:  Malcolm Boyce; Steve Warrington
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

2.  Attenuation of stress-induced gastric lesions by lansoprazole, PD-136450 and ranitidine in rats.

Authors:  S I Chandranath; S M A Bastaki; A D'Souza; A Adem; J Singh
Journal:  Mol Cell Biochem       Date:  2010-11-30       Impact factor: 3.396

3.  Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole.

Authors:  D Gillen; A A Wirz; W D Neithercut; J E Ardill; K E McColl
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

4.  Use of Proton Pump Inhibitors in Hungary: Mixed-Method Study to Reveal Scale and Characteristics.

Authors:  Mária Matuz; Ria Benkő; Zsófia Engi; Krisztina Schváb; Péter Doró; Réka Viola; Mária Szabó; Gyöngyvér Soós
Journal:  Front Pharmacol       Date:  2020-09-08       Impact factor: 5.810

5.  The diagnostic yield of various tests for Helicobacter pylori infection in patients on acid-reducing drugs.

Authors:  Javed Yakoob; Wasim Jafri; Zaigham Abbas; Shahab Abid; Muhammad Islam; Zubair Ahmed
Journal:  Dig Dis Sci       Date:  2007-05-12       Impact factor: 3.199

6.  Attenuated Salmonella typhimurium carrying the hepatocyte growth factor and keratinocyte growth factor genes repairs gastrointestinal mucosal damage caused by chemotherapy.

Authors:  Jun-Zhong Sun; Xiao-Qin Ha; Li-Ming Zhang; Hai-Bin Wang; Hong-Wei Wang; Hai-Feng Duan
Journal:  Med Oncol       Date:  2013-01-19       Impact factor: 3.064

7.  Appropriateness of gastric antisecretory therapy in hospital practice.

Authors:  S S Sebastian; N Kernan; A Qasim; C A O'Morain; M Buckley
Journal:  Ir J Med Sci       Date:  2003 Jul-Sep       Impact factor: 1.568
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.